Zobrazeno 1 - 10
of 35
pro vyhledávání: '"J. Morias"'
Publikováno v:
Mycoses. 22:274-278
Summary: A new oral antimycotic, the imidazole drug ketoconazole, was tested in 67 cases of fungal infections of the skin or the nails. One tablet of 200 mg ketoconazole was given daily. Eighty-five per cent of the patients with dermatomycoses were c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90cdad312aa14535b238bb9a8fcba82b
https://doi.org/10.1111/j.1439-0507.1979.tb01757.x
https://doi.org/10.1111/j.1439-0507.1979.tb01757.x
Publikováno v:
Dermatology. 162:42-50
Oxatomide was evaluated in a double-blind study of 35 patients with chronic urticaria. For 5 weeks patients received at random either 30 mg oxatomide b.i.d. or a placebo. Oxatomide significantly reduced not only the duration of the attacks but also t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::715d9e75d74b063cd6640ec12a278ad8
https://doi.org/10.1159/000250232
https://doi.org/10.1159/000250232
Autor:
D. Willocx, J. Aussems, J. Decroix, H. Campaert, B. Boyden, L. Vanlint, C. Geeraerts, L. Ghekiere, André Bourlond, Dominique Tennstedt, J. Porters, S. Conincx, G. Speelman, T. Kint, V. Vandenhaute, Jean-Marie Lachapelle, J. Morias, R. Vandaele
Publikováno v:
International Journal of Dermatology. 28:410-412
Seventy-eight patients with tinea corporis or tinea cruris participated in a double-blind study with either 100 mg itraconazole or 500 mg ultramicronized griseofulvin for 15 consecutive days. Clinical outcome was significantly in favor of itraconazol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c891fa443df139c6c163de369468aa2b
https://doi.org/10.1111/j.1365-4362.1989.tb02491.x
https://doi.org/10.1111/j.1365-4362.1989.tb02491.x
Publikováno v:
Mykosen. 22(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2ae6611a653e7677c37d5525eb6ad0e
https://pubmed.ncbi.nlm.nih.gov/161994
https://pubmed.ncbi.nlm.nih.gov/161994
Publikováno v:
Arzneimittel-Forschung. 29(7)
59 outpatients (27-82 years) with a chronic leg ulcer participated in a 20-week double-blind placebo-controlled trial of levamisole (levamisole 30; placebo 29). They were instructed to take a body weight adjusted number of tablets (2-5) for two conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::247e07fd209b18f60b2ee6ad9d1eeef6
https://pubmed.ncbi.nlm.nih.gov/387047
https://pubmed.ncbi.nlm.nih.gov/387047
Publikováno v:
Dermatologica. 162(1)
Oxatomide was evaluated in a double-blind study of 35 patients with chronic urticaria. For 5 weeks patients received at random either 30 mg oxatomide b.i.d. or a placebo. Oxatomide significantly reduced not only the duration of the attacks but also t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f542febbe86232d25fd54fbf18f3affb
https://pubmed.ncbi.nlm.nih.gov/7014277
https://pubmed.ncbi.nlm.nih.gov/7014277
Publikováno v:
Archives belges de dermatologie et de syphiligraphie. 23(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0b94c5449f8db57e89c0cd3bd18071d
https://pubmed.ncbi.nlm.nih.gov/4241565
https://pubmed.ncbi.nlm.nih.gov/4241565
Publikováno v:
Archives belges de dermatologie et de syphiligraphie. 21(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2cdf02cbe67b2933bdee3b02dd38f64
https://pubmed.ncbi.nlm.nih.gov/4380968
https://pubmed.ncbi.nlm.nih.gov/4380968
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.